Status:
ACTIVE_NOT_RECRUITING
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Glaucoma
Vision Impairment and Blindness
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The investigators are conducting a 5-year prospective, 2:1 cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved New Yor...
Detailed Description
This study aims to increase engagement, detection and management of glaucoma, vision impairment, cataracts, and other eye diseases in vulnerable populations living in New York City. This study conside...
Eligibility Criteria
Inclusion
- Individuals over age 40
- Living independently in NYCHA housing building or attending DFTA Senior Center
- Willing to answer COVID-19 symptom questions
- Willing to consent for 2 vision screening visits at baseline and 12-month follow-up
Exclusion
- Self-reported terminal illness with life expectancy less than 1 year
- Inability to provide informed consent due to dementia or other reasons
Key Trial Info
Start Date :
September 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 29 2026
Estimated Enrollment :
749 Patients enrolled
Trial Details
Trial ID
NCT04271709
Start Date
September 30 2019
End Date
September 29 2026
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University
New York, New York, United States, 10032